Drug Trial Radar · NCT05536297
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Last checked: Nov 20, 2026Latest source record: May 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
278
Actual
Start
Sep 26, 2022
Primary completion
Apr 10, 2025
Study completion Apr 10, 2025
Sponsor
- Lead sponsor
- Astellas Pharma Global Development, Inc.Astellas (ALPMY)
- Sponsor type
- Industry
- First posted
- Sep 10, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess long-term safety of avacincaptad pegol intravitreal administration for patients with geographic atrophy (GA) who completed Study ISEE2008 (GATHER2) through the Month 23 visit on study treatment (either avacincaptad pegol or Sham).
Conditions
- Geographic Atrophy
- Age-Related Macular Degeneration
Interventions
avacincaptad pegolDrug
Intravitreal Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events (AEs)Time frame: Up to 18 months
Locations
117 sites in 17 countries. Site status is shown where the registry gives one.
Retinal Diagnostic Center
Campbell, California
Eye Medical Center of Fresno
Fresno, California
Retina Consultants of Orange County
Fullerton, California
Jacobs Retina Center at The Shiley Eye Institute USCD
La Jolla, California
Jules Stein Eye Institute David Geffen School of Medicine
Los Angeles, California
Doheny Eye Center, UCLA
Pasadena, California
Retina Consultants of Southern California
Redlands, California
Orange County Retinal Med Group
Santa Ana, California
University of Colorado
Aurora, Colorado
Retina Consultants of Southern CO
Colorado Springs, Colorado
Colorado Retina Associates, PC
Lakewood, Colorado
Rand Eye Institute
Deerfield Beach, Florida
Retina Group of Florida
Fort Lauderdale, Florida
Florida Eye Associates
Melbourne, Florida
Retina Care Specialists
Palm Beach Gardens, Florida
Retina Associates of Sarasota
Sarasota, Florida
Retina Vitreous Associates of Florida
St. Petersburg, Florida
East Florida Eye Institute
Stuart, Florida
Southern Vitreoretinal Associates
Tallahassee, Florida
Center for Retina & Macula Disease
Winter Haven, Florida
Southeast Retina Center P.C.
Augusta, Georgia
Retina Consultants of Hawaii, Inc.
‘Aiea, Hawaii
Illinois Eye Center
Peoria, Illinois
Vitreo Retinal Consultants & Surgeons
Wichita, Kansas
Ochsner Clinic Foundation
New Orleans, Louisiana
The Retina Group of Washington
Chevy Chase, Maryland
Cumberland Valley Retina Consultants
Hagerstown, Maryland
Ophthalmic Consultants of Boston
Boston, Massachusetts
Retina Research Institute at New England Retina
Springfield, Massachusetts
Vitreoretinal Associates PC
Worcester, Massachusetts
Sierra Eye Associates
Reno, Nevada
Retina Vitreous Surgeons of Central New York
Liverpool, New York
Ophthalmic Consultants of Long Island
Oceanside, New York
Retina Associates of Western NY
Rochester, New York
Western Carolina Retinal Associates
Asheville, North Carolina
Retina & Vitreous Center of Southern Oregon, PC
Ashland, Oregon
Retina Northwest PC
Portland, Oregon
Eye Health Northwest
Portland, Oregon
Mid Atlantic Retina - Wills Eye Institute
Philadelphia, Pennsylvania
Associates in Ophthalmology
West Mifflin, Pennsylvania
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.